[Early cardiac remodeling in short-duration T2DM: Benchmarking 85 cases against norms in an Algerian population].

Authors

C Zemit, A Lounici, E Tabti, Y Meftah, S Ghaib, W Hammadi, S Mesbahi

Published in

Annales de cardiologie et d'angeiologie. Oct 29, 2026. Epub Oct 29, 2026.

Abstract

Diabetic cardiomyopathy is traditionally viewed as a late complication of chronic hyperglycemia, but emerging evidence suggests it may manifest early in type 2 diabetes mellitus (T2DM), preceding prolonged metabolic exposure.
To determine whether early cardiac remodeling markers, particularly diastolic dysfunction, are already present in patients with short-duration T2DM (< 5 years).
We conducted a cross-sectional study of 86 T2DM patients at a university hospital in an Algerian population (2024). Echocardiography was performed using a GE Vivid E95 system. Diastolic dysfunction was defined using ASE/EACVI criteria. Multivariable logistic regression identified independent predictors.
Diastolic dysfunction was present in 20% (17/86) of patients despite recent disease onset. The study population had a mean diabetes duration of 1.8±2.0 years, mean age of 54.7±8.9 years, and mean HbA1c of 8.9±0.27%. Hypertension was present in 35.3% (30/86) of patients, and obesity (BMI≥30kg/m²) in 29.5% (25/86). Impaired myocardial relaxation was widespread: lateral e'<10cm/s in 49.4%, septal e'<7cm/s in 24.4%, and elevated E/e' in 29.1%. Contrary to traditional assumptions, dysfunction was not significantly different between well-controlled (HbA1c<7%) and poorly controlled patients (27.3 vs. 17.2%, P=0.356). Systolic blood pressure was the only independent predictor of diastolic dysfunction (OR 1.07 per mmHg, 95% CI 1.02-1.13, P=0.008). Neither HbA1c (P=0.324) nor diabetes duration (P=0.863) showed significant associations.
Early cardiac remodeling occurs frequently in short-duration T2DM, independent of glycemic control and disease chronicity. This challenges the traditional view that diabetic cardiomyopathy requires prolonged hyperglycemia. Systolic blood pressure is the sole predictor, suggesting mechanisms beyond metabolic control alone. Systematic echocardiographic screening at T2DM diagnosis may be warranted to detect subclinical dysfunction and prevent progression to heart failure.

PMID:
42957560
Bibliographic data and abstract were imported from PubMed on 30 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.